• 

  Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma 

  Kalish, JM; Doros, L; Helman, LJ; Hennekam, RC; Kuiper, RP; Maas, SM; Maher, ERNichols, KEPlon, SEPorter, CCRednam, SSchultz, KAPStates, LJTomlinson, GEZelley, KDruley, TE et al. (American Association for Cancer Research, 2017-07-02)

  A number of genetic syndromes have been linked to increased risk for Wilms tumor (WT), hepatoblastoma (HB), and other embryonal tumors. Here, we outline these rare syndromes with at least a 1% risk to develop these tumors ...
• 

  Polyglutamine tracts regulate autophagy 

  Ashkenazi, A; Bento, CF; Ricketts, T; Vicinanza, M; Siddiqi, F; Pavel, M; Squitieri, FHardenberg, MCImarisio, SMenzies, FMRubinsztein, DC et al. (Taylor & Francis, 2017-07-27)

  Expansions of polyglutamine (polyQ) tracts in different proteins cause 9 neurodegenerative conditions, such as Huntington disease and various ataxias. However, many normal mammalian proteins contain shorter polyQ tracts. ...
• 

  A case of a metastatic SDHA mutated paraganglioma re-presenting 23 years after initial surgery. DOI: 10.1530/ERC-17-0206 

  Casey, RC; Maher, ERM
• 

  A comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status 

  Fitzgerald, R; Tischkowitz, M; Di Pietro, M; O'Donovan, M; Richardson, S; Mi, EM; Mi, EHardwick, RZiauddeen, HFletcher, PCCaldas, CRagunath, K et al. (Elsevier, 2017-07-06)

  Background and aims Hereditary Diffuse Gastric Cancer (HDGC) accounts for 1% of gastric cancer cases. For patients with a germline CDH1 mutation, risk-reducing gastrectomy is recommended. However, for those delaying surgery ...

View more